Microrna-21: A Central Regulator of Fibrotic Diseases Via Various Targets

E-ISSN： 1873-4286|21|17|2236-2242

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.21, Iss.17, 2015-05, pp. : 2236-2242

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

MicroRNA-21 with therapeutic potential in autoimmune diseases

By Xu Wang-Dong

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 6, 2013-09 ,pp. : 659-665

Informa Healthcare

Access to resources Recommend Favorite

Tankyrase as a Novel Molecular Target in Cancer and Fibrotic Diseases

Current Drug Targets, Vol. 18, Iss. 10, 2017-07 ,pp. : 1214-1224

Bentham Science Publishers

Access to resources Recommend Favorite

microRNA as Biomarkers and Regulator of Cardiovascular Development and Disease

Current Pharmaceutical Design, Vol. 20, Iss. 14, 2014-04 ,pp. : 2347-2370

Bentham Science Publishers

Access to resources Recommend Favorite

Screening of entomopathogenic Deuteromycetes for activities on targets involved in degenerative diseases of the central nervous system

By Schmidt K. Li Z. Schubert B. Huang B. Stoyanova S. Hamburger M.

Journal of Ethnopharmacology, Vol. 89, Iss. 2, 2003-12 ,pp. : 251-260

Elsevier

Access to resources Recommend Favorite

Modulation of transcriptional activity of collagen genes for the treatment of fibrotic diseases

By Rosenbloom Joel Jimenez Sergio A

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 5, 2002-05 ,pp. : 657-664

Informa Healthcare

Access to resources Recommend Favorite